Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 184

1.

Implication of low risk human papillomaviruses, HPV6 and HPV11 in laryngeal papillomatosis in Burkina Faso.

Ilboudo M, Zohoncon TM, Traore IMA, Traore EMA, Kande A, Obiri-Yeboah D, Djigma FW, Gyebre YMC, Simpore J.

Am J Otolaryngol. 2019 Feb 18. pii: S0196-0709(18)31094-9. doi: 10.1016/j.amjoto.2019.02.003. [Epub ahead of print]

PMID:
30799210
2.

Residual risk of HIV, HCV, and HBV transmission by blood transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso.

Yooda AP, Sawadogo S, Soubeiga ST, Obiri-Yeboah D, Nebie K, Ouattara AK, Diarra B, Simpore A, Yonli YD, Sawadogo AG, Drabo BE, Zalla S, Siritié AP, Nana RS, Dahourou H, Simpore J.

J Blood Med. 2019 Feb 1;10:53-58. doi: 10.2147/JBM.S189079. eCollection 2019. Review.

3.

APOBEC3G expression and HIV-1 infection in Burkina Faso.

Compaore TR, Soubeiga ST, Ouattara AK, Tchelougou D, Bisseye C, Bakouan DR, Compaore I, Dembele A, Yonli AT, Obiri-Yeboah D, Djigma WF, Simpore J.

J Public Health Afr. 2018 Dec 21;9(3):907. doi: 10.4081/jphia.2018.907. eCollection 2018 Dec 21.

4.

Prevention of mother-to-child transmission of hepatitis B virus in Burkina Faso: Screening, vaccination and evaluation of post-vaccination antibodies against hepatitis B surface antigen in newborns.

Yelemkoure ET, Yonli AT, Montesano C, Ouattara AK, Diarra B, Zohoncon TM, Nadembega CWM, Ouedraogo P, Sombié C, Soubeiga ST, Tao I, Gansane A, Amicosante M, Djigma F, Obiri-Yeboah D, Pietra V, Simpore J, Colizzi V.

J Public Health Afr. 2018 Dec 21;9(3):816. doi: 10.4081/jphia.2018.816. eCollection 2018 Dec 21.

5.

Genetic diversity of hepatitis viruses in West-African countries from 1996 to 2018.

Assih M, Ouattara AK, Diarra B, Yonli AT, Compaore TR, Obiri-Yeboah D, Djigma FW, Karou S, Simpore J.

World J Hepatol. 2018 Nov 27;10(11):807-821. doi: 10.4254/wjh.v10.i11.807. Review.

6.

[Corrigendum: Ethnobotanical study of plants used in the treatment of diabetes in the traditional medicine of Maritime Region, Togo].

Gbekley HE, Karou DS, Gnoula C, Kodjovi, Anani AK, Tchacondo T, Agbonon A, Batawila K, Simpore J.

Pan Afr Med J. 2018 Jun 28;30:186. doi: 10.11604/pamj.2018.30.186.15483. eCollection 2018. French.

7.

Insights into the Interplay between KIR Gene Frequencies and Chronic HBV Infection in Burkina Faso.

Sorgho PA, Martinson JJ, Djigma FW, Yonli AT, Nagalo BM, Compaore TR, Obiri-Yeboah D, Diarra B, Sombie HK, Zongo AW, Ouattara AK, Soubeiga STR, Traore L, Roberts LR, Simpore J.

Mediterr J Hematol Infect Dis. 2018 Nov 1;10(1):e2018060. doi: 10.4084/MJHID.2018.060. eCollection 2018.

8.

A case report of Villar's nodule in a woman without surgical history.

Ouédraogo NLM, Ilboudo S, Ouattara AK, Ouedraogo AS, Zida M, Zongo N, Obiri-Yeboah D, Ouangre E, Simpore J, Traore SS.

Int J Surg Case Rep. 2018;53:186-188. doi: 10.1016/j.ijscr.2018.10.066. Epub 2018 Nov 1.

9.

Oncogenic human papillomavirus infection and genotypes characterization among sexually active women in Tenkodogo at Burkina Faso, West Africa.

Ouedraogo RA, Zohoncon TM, Guigma SP, Angèle Traore IM, Ouattara AK, Ouedraogo M, Djigma FW, Obiri-Yeboah D, Ouedraogo C, Simpore J.

Papillomavirus Res. 2018 Dec;6:22-26. doi: 10.1016/j.pvr.2018.09.001. Epub 2018 Sep 19.

10.

World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal.

Diarra B, Yonli AT, Ouattara AK, Zohoncon TM, Traore L, Nadembega C, Obiri-Yeboah D, Yara J, Pietra V, Ouedraogo P, Bougouma A, Sanogo R, Simpore J.

Virol J. 2018 Aug 6;15(1):121. doi: 10.1186/s12985-018-1032-5.

11.

Human immunodeficiency virus type 1 drug resistance in a subset of mothers and their infants receiving antiretroviral treatment in Ouagadougou, Burkina Faso.

Soubeiga ST, Bazie BVJTE, Compaore TR, Ouattara AK, Zohoncon TM, Obiri-Yeboah D, Yonli AT, Zongo A, Traore L, Pietra V, Akpona S, Diagbouga S, Simpore J.

J Public Health Afr. 2018 Jul 6;9(1):767. doi: 10.4081/jphia.2018.767. eCollection 2018 May 21.

12.

BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso.

Zoure AA, Slaoui M, Bambara HA, Sawadogo AY, Compaoré TR, Ouédraogo NLM, Mzibri ME, Attaleb M, Traoré SS, Simpore J, Bakri Y.

J Public Health Afr. 2018 Jul 6;9(1):663. doi: 10.4081/jphia.2018.663. eCollection 2018 May 21.

13.

Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study.

Ndila CM, Uyoga S, Macharia AW, Nyutu G, Peshu N, Ojal J, Shebe M, Awuondo KO, Mturi N, Tsofa B, Sepúlveda N, Clark TG, Band G, Clarke G, Rowlands K, Hubbart C, Jeffreys A, Kariuki S, Marsh K, Mackinnon M, Maitland K, Kwiatkowski DP, Rockett KA, Williams TN; MalariaGEN Consortium.

Lancet Haematol. 2018 Aug;5(8):e333-e345. doi: 10.1016/S2352-3026(18)30107-8. Epub 2018 Jul 20.

14.

Impact of Multiplex PCR in Reducing the Risk of Residual Transfusion-Transmitted Human Immunodeficiency and Hepatitis B and C Viruses in Burkina Faso.

Yooda AP, Soubeiga ST, Nebie KY, Diarra B, Sawadogo S, Ouattara AK, Obiri-Yeboah D, Yonli AT, Tao I, Sorgho PA, Dahourou H, Simpore J.

Mediterr J Hematol Infect Dis. 2018 Jul 1;10(1):e2018041. doi: 10.4084/MJHID.2018.041. eCollection 2018.

15.

Breast cancer: descriptive profile of 80 women attending breast cancer care in the Department of General and Digestive Surgery of CHU-YO.

Bambara HA, Zouré AA, Sawadogo AY, Ouattara AK, Ouédraogo NLM, Traoré SS, Bakri Y, Simpore J.

Pan Afr Med J. 2017 Dec 26;28:314. doi: 10.11604/pamj.2017.28.314.10203. eCollection 2017.

16.

Cymbopogon citratus and Cymbopogon giganteus essential oils have cytotoxic effects on tumor cell cultures. Identification of citral as a new putative anti-proliferative molecule.

Bayala B, Bassole IHN, Maqdasy S, Baron S, Simpore J, Lobaccaro JA.

Biochimie. 2018 Oct;153:162-170. doi: 10.1016/j.biochi.2018.02.013. Epub 2018 Mar 6.

PMID:
29501481
17.

Sero-prevalence and risk factors for hepatitis E virus infection among pregnant women in the Cape Coast Metropolis, Ghana.

Obiri-Yeboah D, Asante Awuku Y, Adu J, Pappoe F, Obboh E, Nsiah P, Amoako-Sakyi D, Simpore J.

PLoS One. 2018 Jan 25;13(1):e0191685. doi: 10.1371/journal.pone.0191685. eCollection 2018.

18.

Occult Hepatitis B Virus Infection and Associated Genotypes among HBsAg-negative Subjects in Burkina Faso.

Diarra B, Yonli AT, Sorgho PA, Compaore TR, Ouattara AK, Zongo WA, Tao I, Traore L, Soubeiga ST, Djigma FW, Obiri-Yeboah D, Nagalo BM, Pietra V, Sanogo R, Simpore J.

Mediterr J Hematol Infect Dis. 2018 Jan 1;10(1):e2018007. doi: 10.4084/MJHID.2018.007. eCollection 2018.

19.

Prevalence, genetic variants and clinical implications of G-6-PD deficiency in Burkina Faso: a systematic review.

Ouattara AK, Yameogo P, Traore L, Diarra B, Assih M, Compaore TR, Obiri-Yeboah D, Soubeiga ST, Djigma FW, Simpore J.

BMC Med Genet. 2017 Nov 23;18(1):139. doi: 10.1186/s12881-017-0496-2. Review.

20.

Molecular Epidemiology of Rotavirus in Children under Five in Africa (2006-2016): A Systematic Review.

Ouermi D, Soubeiga D, Nadembega WMC, Sawadogo PM, Zohoncon TM, Obiri-Yeboah D, Djigma FW, Nordgren J, Simpore J.

Pak J Biol Sci. 2017;20(2):59-69. doi: 10.3923/pjbs.2017.59.69. Review.

PMID:
29022996

Supplemental Content

Loading ...
Support Center